Home / Research / Manufacturers / Thermo Fisher Scientific Medical-device intelligence
Thermo Fisher Scientific: FDA clearances and recalls Research Thermo Fisher Scientific in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
Names and coverage This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
Names observed in the source
Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.
Product codes in this company’s records Record activity in this scope 64 clearance records and 5 recall records in the covered releases, across 1 source company names and 16 product codes. Dated history runs from May 22, 2007 to Sep 25, 2025.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 0 0 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 0 0 May 2026 0 0 June 2026 0 0 July 2026 0 0 August 2026 0 0 September 2026 0 0 October 2026 0 0
Product codes represented Code and FDA device name Clearances Recalls JWY · Manual Antimicrobial Susceptibility Test Systems 47 0 NGZ · Susceptibility Test Plate, Antifungal 5 0 IDP · Microtome, Cryostat 0 2 JSO · Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar 2 0 LRG · Instrument For Auto Reader & Interpretation Of Overnight Suscept. Systems 2 0 CGZ · Electrode, Ion-Specific, Chloride 1 0 DHB · System, Test, Radioallergosorbent (Rast) Immunological 1 0 DIF · Drug Mixture Control Materials 1 0 DJR · Enzyme Immunoassay, Methadone 1 0 DLJ · Calibrators, Drug Specific 1 0 DOP · Mass Spectrometer, Clinical Use 0 1 IEO · Processor, Tissue, Automated 0 1
All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 69 matching records Device / record Company in FDA record Source Source date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mL K252062 · JWYThermo Fisher Scientific 510(k) Sep 25, 2025FDA decision date The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mL K250575 · JWYThermo Fisher Scientific 510(k) Sep 5, 2025FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mL K252014 · JWYThermo Fisher Scientific 510(k) Aug 28, 2025FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mL K250990 · JWYThermo Fisher Scientific 510(k) Jun 30, 2025FDA decision date The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Ceftobiprole in the d… K242843 · JWYThermo Fisher Scientific 510(k) Jun 20, 2025FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Vancomycin in the dilution range of 0.25-128 ug/mL K242659 · JWYThermo Fisher Scientific 510(k) May 22, 2025FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Moxifloxacin in the dilution range of 0.008-16 ug/mL K242658 · JWYThermo Fisher Scientific 510(k) Apr 15, 2025FDA decision date The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mL K243738 · NGZThermo Fisher Scientific 510(k) Feb 27, 2025FDA decision date The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Linezolid in the dilu… K242905 · JWYThermo Fisher Scientific 510(k) Feb 10, 2025FDA decision date The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with penicillin in the dil… K243201 · JWYThermo Fisher Scientific 510(k) Feb 10, 2025FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ceftobiprole in the dilution range of 0.008-16 ug/mL K243169 · JWYThermo Fisher Scientific 510(k) Dec 19, 2024FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Linezolid in the dilution range of 0.25-32 ug/mL K242653 · JWYThermo Fisher Scientific 510(k) Dec 5, 2024FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Daptomycin in the dilution range of 0.03-64 ug/mL K242657 · JWYThermo Fisher Scientific 510(k) Nov 26, 2024FDA decision date The Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Meropenem in the di… K242021 · JWYThermo Fisher Scientific 510(k) Oct 9, 2024FDA decision date The Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with ceftriaxone in the … K241967 · JWYThermo Fisher Scientific 510(k) Oct 1, 2024FDA decision date The Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Imipenem in the dil… K240445 · JWYThermo Fisher Scientific 510(k) May 16, 2024FDA decision date Sensititre 20-24 hour Haemophilus influenzaelStreptococcus pneumoniae MIC or Breakpoint Susceptibility System with Ceftolozane-tazobactam in the … K232310 · JWYThermo Fisher Scientific 510(k) Oct 31, 2023FDA decision date The Sensititre YeastOne Susceptibility System with Rezafungin in the dilution range of 0.008-8ug/mL K231433 · NGZThermo Fisher Scientific 510(k) Aug 31, 2023FDA decision date Sensititre 20-24-hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Dalbavancin in the dilution ra… K231988 · JWYThermo Fisher Scientific 510(k) Aug 30, 2023FDA decision date Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Sulbactam-durlobactam in the dilution range of 0.015/4-32/4 ug/mL K231994 · JWYThermo Fisher Scientific 510(k) Aug 25, 2023FDA decision date Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC, or Breakpoint Susceptibility System with Imipenem-relebactam in the di… K230935 · JWYThermo Fisher Scientific 510(k) Jun 30, 2023FDA decision date Sensititre 20-24-hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Delafloxacin in the dilution r… K223844 · JWYThermo Fisher Scientific 510(k) Mar 21, 2023FDA decision date Sensititre YeastOne Susceptibility System with Fluconazole in the dilution range of 0.12-128ug/mL K221198 · NGZThermo Fisher Scientific 510(k) Mar 10, 2023FDA decision date The Sensititre YeastOne Susceptibility System with Caspofungin in the dilution range of 0.015-16ug/ml K221899 · NGZThermo Fisher Scientific 510(k) Jan 20, 2023FDA decision date Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Cefiderocol in the dilution range of 0.03-64 ug/ml K203741 · JWYThermo Fisher Scientific 510(k) Dec 20, 2021FDA decision date
Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗